Welcome to the e-CCO Library!

P0707: Impact of age of disease diagnosis on disease phenotype and severity in patients with Inflammatory Bowel Diseases
Year: 2025
Source: ECCO'25
Authors: Panayiotoux7x7x7 S.(1)*;Orfanoudakix7x7x7 E.(1x7x7x72);Papatzeloux7x7x7 I.(1);Foteinogiannopouloux7x7x7 K.(1);Theodorakix7x7x7 E.(1);Drygiannakisx7x7x7 I.(1);E. Koutroubakisx7x7x7 I.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0708: Advanced Therapies in Elderly Patients with Inflammatory Bowel Disease: A Comparative Retrospective Cohort Study in Taiwan
Year: 2025
Source: ECCO'25
Authors: Linx7x7x7 S.H.(1)*;Chiux7x7x7 H.Y.(2);Kuox7x7x7 C.J.(3x7x7x74x7x7x75);Chenx7x7x7 C.M.(5x7x7x76);Wux7x7x7 R.C.(7);Chiux7x7x7 C.T.(3x7x7x74x7x7x75); Sux7x7x7 M.Y.(1);Changx7x7x7 C.W.(8);Panx7x7x7 Y.B.(9); Lex7x7x7 P.H.(3x7x7x74x7x7x75);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0709: Patient Satisfaction with Subcutaneous versus Intravenous Vedolizumab: A Prospective Observational Study
Year: 2025
Source: ECCO'25
Authors: Herrera De Guisex7x7x7 C.M.(1)*;Serra-Ruizx7x7x7 X.(1);Céspedes Martínezx7x7x7 E.(1);Mayorga Ayalax7x7x7 L.(1);Robles Alonsox7x7x7 V.(1);Lastiri Gonzalezx7x7x7 E.(1);Ollerx7x7x7 E.(1);Pérez Martínezx7x7x7 Z.(1);Casellasx7x7x7 F.(1);Borruel Sainzx7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P070: Efficacy of a novel non-covalent oral small molecule Nrf2 activator in a rat model of Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Murray, C.(1);Cooper, N.(1);Lucas, C.L.(1);Manso, A.S.(1);Ray, N.C.(1);Worthington, J.(2);Fox, J.C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P070: Global cytokine—cytokine interaction framework to uncover communication channels between elements of the immune system
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Olbei, M.(1)*;Modos, D.(2,3);Cozzetto, D.(1);Powell, N.(1);Korcsmaros, T.(1,2,3);
Created: Friday, 14 July 2023, 10:48 AM
P070: Mucosal immune signature in IBD: To what extent α4β7-expressing peripheral T cells reflect T-lymphocyte population resident in gut mucosa?
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Reich-Zeliger1, N. Friedman1, L. Lichtenstein2,3*

Created: Thursday, 21 February 2019, 9:14 AM
P070: Novel long-acting lipidated interleukin-22 normalises colonic inflammation in an acute DSS colitis model
Year: 2022
Source: ECCO'22
Authors: Van De Bunt, M.(1);Norrild, J.C.(2);Sass-Ørum, K.(3);Kjølbye, A.L.(1);Jorgensen, R.(1);
Created: Friday, 11 February 2022, 3:52 PM
P070: The influence of vitamin D on M1 and M2 macrophages in patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

E. Seidman*, S. Dionne

Created: Friday, 22 February 2019, 9:49 AM
P070: The level of nuclear factor kappa B (NF-kB) translocation during infliximab therapy in children with IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Petrichuk1, T. Radigina1, D. Gerasimova1, A. Illarionov2,3, A. Anushenko2, T. Erlikh-Fox4, A. Potapov*2

Created: Friday, 22 February 2019, 9:41 AM
P070: TNFα production by classical monocytes is poorly controlled by IL-10 in patients with IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hoti I., McCarthy N.E., Giles E.M., Ayada I., Gordon H., Stagg A.J., Lindsay J.O.

Created: Wednesday, 20 February 2019, 10:36 AM
P071 Studying the effects of the probiotic bifidobacteria on gut health and intestinal epithelial cells function
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Poletti1, I. Hautefort1, A. Treveil1,2, A. Demeter1, E. Rodriguez1, A. Brion2, A. Goldson2, D. Divekar3, Z. Schofield2, I. O’Neill2, A. Lister1, J. Lipscombe1, A. Watson3,4, I. Macaulay1, L. Hall2, T. Korcsmaros1,2

Created: Thursday, 30 January 2020, 10:12 AM
P0710: Effectiveness and Safety of Filgotinib After One Year in Patients with Ulcerative Colitis: Preliminary Results from the Filguito Registry in Andalusia (Spain)
Year: 2025
Source: ECCO'25
Authors: Caballero Mateosx7x7x7 A.M.(1)*;Suárez-Toribiox7x7x7 Á.(2);Trigo-Saladox7x7x7 C.(3);Rodríguez-Gonzálezx7x7x7 F.J.(4);Silva-Albarellosx7x7x7 E.(5);Martín-Rodríguezx7x7x7 M.D.M.(6);Gijón-Villanovax7x7x7 R.(7);Gómez-Delgadox7x7x7 E.(8);Benítezx7x7x7 J.M.(9);Trapero-Martínezx7x7x7 A.M.(10);Hernández-Martínezx7x7x7 Á.(11);Olmedo-Martínx7x7x7 R.V.(12);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0711: The Effect of Extraintestinal Manifestations Presence on Treatment Persistence in IBD Treatment
Year: 2025
Source: ECCO'25
Authors: Koçx7x7x7 Ö.(1)*;Eroglux7x7x7 Z.(1);Yılmazx7x7x7 V.(1);Acehanx7x7x7 M.F.(1);Guvenirx7x7x7 S.T.(1);Torunerx7x7x7 M.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0712: Feasibility of a smart toilet seat for the measurement of physiological parameters in active Ulcerative Colitis: A pilot study.
Year: 2025
Source: ECCO'25
Authors: Hazelegerx7x7x7 L.(1x7x7x72)*;Verbiestx7x7x7 V.(3);Hamersx7x7x7 J.(3);Groenendaalx7x7x7 W.(4x7x7x75);Wentinkx7x7x7 E.(3);Duijvesteinx7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0713: Feasibility of a Physical Activity intervention in Patients with IBD - the PASIBO Study
Year: 2025
Source: ECCO'25
Authors: Poulsenx7x7x7 A.(1)*;Thomsenx7x7x7 T.(2x7x7x73); Villumsenx7x7x7 M.(2);Søe Riis Jespersenx7x7x7 H.(4);Blædel Hansenx7x7x7 A.(2);Appel Esbensenx7x7x7 B.(5x7x7x76);Jessx7x7x7 T.(7);Højgaard Allinx7x7x7 K.(7);Aadahlx7x7x7 M.(2x7x7x76);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0714: Low risk of recurrent or new neoplasia after immunomodulatory therapy in patients with Inflammatory Bowel Disease and previous cancer: a multicentre retrospective Italian study
Year: 2025
Source: ECCO'25
Authors: Manconex7x7x7 R.(1);Nerix7x7x7 B.(1)*;Bonaccix7x7x7 L.(2);Fiorillox7x7x7 M.(1);Schiavonex7x7x7 S.C.(1);Sparacinox7x7x7 A.(3);Testa x7x7x7 A.(2);Festa x7x7x7 S.(4);Marafinix7x7x7 I.(1);Orlandox7x7x7 A.(3);Castiglionex7x7x7 F.(5);Friesx7x7x7 W.(6);Calabresex7x7x7 E.(1);Monteleonex7x7x7 G.(1);Bianconex7x7x7 L.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0715: Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data
Year: 2025
Source: ECCO'25
Authors: Kandemirx7x7x7 H.(1)*;Karataşx7x7x7 A.(1);Moralx7x7x7 K.(1);Bilicanx7x7x7 G.(1);Kekillix7x7x7 M.(1);Cindorukx7x7x7 M.(1);Karakanx7x7x7 T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0716: Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced perianal Crohn's Disease patients: A Single Center Experience
Year: 2025
Source: ECCO'25
Authors: Eroglux7x7x7 Z.(1);Acehanx7x7x7 M.F.(1);Koçx7x7x7 Ö.(1)*;Yılmazx7x7x7 V.(1);Torunerx7x7x7 M.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0717: Real-world data of Mirikizumab in the induction and maintenance therapy for ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Eleftheriadoux7x7x7 A.M.(1)*;Hegazyx7x7x7 A.N.(1);Juhranx7x7x7 K.S.(1);Siegmundx7x7x7 B.(1);Sonnenbergx7x7x7 E.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0718: Ulcerative Proctitis: Adherence to Guidelines and confirmation of clinicalx7x7x7 biochemical and endoscopic remission in phenotypically E1 patients.
Year: 2025
Source: ECCO'25
Authors: Malkopoulosx7x7x7 A.(1)*;Gluchx7x7x7 A.(2);Kakkadasam Ramaswamy x7x7x7 P.(1);Mohsen x7x7x7 W.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session